BAFNA PHARMACEUTICALS
Back to Cashflow Statement
|
BAFNA PHARMACEUTICALS Last 5 Year Net Cash Inflow / Outflow History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-1.41 Cr | ₹2.04 Cr | ₹-6.41 Cr | ₹7.64 Cr | ₹-1.63 Cr |
What is the latest Net Cash Inflow / Outflow ratio of BAFNA PHARMACEUTICALS ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹-1.41 Cr |
| Mar2025 | ₹2.04 Cr |
| Mar2024 | ₹-6.41 Cr |
| Mar2023 | ₹7.64 Cr |
| Mar2022 | ₹-1.63 Cr |
How is Net Cash Inflow / Outflow of BAFNA PHARMACEUTICALS Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹-1.41 Cr | Negative | |
| Mar2025 | ₹2.04 Cr | Positive | |
| Mar2024 | ₹-6.41 Cr | Negative | |
| Mar2023 | ₹7.64 Cr | Positive | |
| Mar2022 | ₹-1.63 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹1,114.5 Cr | -0.9% | 2.4% | 208.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,299.0 Cr | 1.2% | 9.1% | 6.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹297,325.0 Cr | -2.7% | 22.2% | 70% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹178,727.0 Cr | -1% | 2% | 20.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,145.0 Cr | 1.5% | 13% | 12.1% | Stock Analytics | |
| CIPLA | ₹114,312.0 Cr | 1.7% | 7.8% | -7.3% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | -0.9% |
2.4% |
208.8% |
| SENSEX | 2.9% |
13.9% |
-0.8% |
You may also like the below Video Courses